Rtw Investments, LP Acadia Pharmaceuticals Inc Transaction History

Rtw Investments, LP

$6.51 Billion
Q2 2025

A detailed history of Rtw Investments, LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Rtw Investments, LP holds 8,995,547 shares of ACAD stock, worth $212 Million. This represents 2.98% of its overall portfolio holdings.

Number of Shares

8,995,547

Previous 8,540,117 5.33%

Holding current value

$212 Million

Previous $142 Million 36.79%

% of portfolio

2.98%

Previous 2.32%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$14.1 - $22.95 $6.42 Million - $10.5 Million	455,430 Added 5.33%	8,995,547 $194 Million
Q1 2025 May 15, 2025	SELL	$16.61 - $20.29 $2.75 Million - $3.36 Million	-165,384 Reduced 1.9%	8,540,117 $142 Million
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $71.5 Million - $93.8 Million	-5,002,005 Reduced 36.49%	8,705,501 $160 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $1.78 Million - $2.24 Million	-121,809 Reduced 0.88%	13,707,506 $223 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $45.8 Million - $79.5 Million	2,575,764 Added 22.89%	13,829,315 $256 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $6.71 Million - $10.3 Million	-322,986 Reduced 2.79%	11,253,551 $352 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $37.4 Million - $60 Million	1,793,288 Added 18.33%	11,576,537 $241 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $27.4 Million - $39.5 Million	1,540,385 Added 18.69%	9,783,249 $234 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $74.6 Million - $95.6 Million	4,571,926 Added 124.54%	8,242,864 $155 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $7.81 Million - $10.1 Million	-553,171 Reduced 13.1%	3,670,938 $60.1 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $55 Million - $115 Million	4,224,109 New	4,224,109 $59.5 Million

Others Institutions Holding ACAD

# of Institutions

346

Shares Held

165M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.82B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account

Rtw Investments, LP Acadia Pharmaceuticals Inc Transaction History